XML 66 R38.htm IDEA: XBRL DOCUMENT v3.19.2
Segment Information (Tables)
 12 Months Ended
Jun. 30, 2019
Segment Reporting [Abstract]  
Revenue by Reportable Segment
The following table presents revenue for each reportable segment and Corporate:
(in millions)
2019
 
2018
 
2017
Pharmaceutical
$
129,917

 
$
121,241

 
$
116,463

Medical
15,633

 
15,581

 
13,524

Total segment revenue
145,550

 
136,822

 
129,987

Corporate (1)
(16
)
 
(13
)
 
(11
)
Total revenue
$
145,534

 
$
136,809

 
$
129,976


(1)
Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Disaggregation of Revenue [Table Text Block]
The following table presents disaggregated revenue within our two reportable segments:
 
2019
(in millions)
 
Pharmaceutical Distribution and Specialty Solutions (1)
$
129,067

Nuclear and Precision Health Solutions
850

Pharmaceutical segment revenue
129,917

Medical distribution and products (2)
13,833

Cardinal Health at-Home Solutions
1,800

Medical segment revenue
15,633

  Total segment revenue
145,550

Corporate (3)
(16
)
Total revenue
$
145,534

(1)
Products and services offered by our Specialty Solutions division are referred to as “specialty pharmaceutical products and services"
(2)
Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division
(3)
Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Revenue from External Customers by Geographic Areas [Table Text Block]
The following table presents revenue by geographic area:
(in millions)
2019
 
2018
 
2017
United States
$
141,479

 
$
132,539

 
$
125,017

International
4,071

 
4,283

 
4,970

Total segment revenue
145,550

 
136,822

 
129,987

Corporate (1)
(16
)
 
(13
)
 
(11
)
Total revenue
$
145,534

 
$
136,809

 
$
129,976

(1)
Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Segment Profit by Reportable Segment
The following tables present segment profit by reportable segment and Corporate:
(in millions)
2019
 
2018
 
2017
Pharmaceutical
$
1,834

 
$
1,992

 
$
2,187

Medical
576

 
662

 
572

Total segment profit
2,410

 
2,654

 
2,759

Corporate
(350
)
 
(2,528
)
 
(639
)
Total operating earnings
$
2,060

 
$
126

 
$
2,120
Depreciation and Amortization and Additions to Property and Equipment by Reportable Segment
The following tables present depreciation and amortization and additions to property and equipment by reportable segment and Corporate:
(in millions)
2019
 
2018
 
2017
Pharmaceutical
$
147

 
$
156

 
$
122

Medical
288

 
278

 
156

Corporate
565

 
598

 
439

Total depreciation and amortization
$
1,000

 
$
1,032

 
$
717

(in millions)
2019
 
2018
 
2017
Pharmaceutical
$
35

 
$
58

 
$
50

Medical
74

 
127

 
123

Corporate
219

 
199

 
214

Total additions to property and equipment
$
328

 
$
384

 
$
387
Assets by Reportable Segment
The following table presents total assets for each reportable segment and Corporate at June 30:
(in millions)
2019
 
2018
 
2017
Pharmaceutical
$
22,446

 
$
21,421

 
$
21,848

Medical
15,284

 
16,066

 
10,688

Corporate
3,233

 
2,464

 
7,576

Total assets
$
40,963

 
$
39,951

 
$
40,112
Property and Equipment, Net by Geographic Area
The following tables present property and equipment, net by geographic area:
(in millions)
2019
 
2018
 
2017
United States
$
1,846

 
$
1,950

 
$
1,623

International
510

 
537

 
256

Property and equipment, net
$
2,356

 
$
2,487

 
$
1,879